Antitrust Webinar Series

The webinar series is hosted by a team of cross-disciplinary Perkins Coie lawyers who will provide a monthly overview and discussion forum on a critical hot topic in antitrust and consumer protection.
Upcoming Sessions
July 10, 2025
The State of Merger Enforcement
As antitrust law continues to be a hot-button political issue, antitrust merger enforcement is rapidly evolving. Six months into the Trump administration, we've seen its first merger challenges but also an openness to the settlements the Biden administration disfavored. State enforcers are also increasingly signaling a desire to investigate and challenge mergers with two states, Washington and Colorado, enacting pre-merger notification laws. What will the next six months of enforcement look like? What does all this mean for businesses and how can you prepare for potential merger investigations?
Past Sessions
June 12, 2025
How Not To Be a Bad Apple: Lessons From the Epic v. Apple Injunction Ruling
In a landmark decision, a federal judge found that Apple had failed to comply with a court order in the high-profile Epic Games antitrust case. Join our webinar as we unpacked the far-reaching implications of this ruling for the broader tech industry. We explored the court’s decision, a recent European Union decision against Apple, and what it all meant for digital marketplaces, payment systems, developers, and the enforcement of unfair competition laws.
May 08, 2025
Consumer Protection and Privacy: The State of Play
With the Federal Trade Commission in a time of transition, hear about what was expected at the federal and state levels regarding the shifting landscape of consumer protection, including privacy
April 10, 2025
Pharmaceutical Antitrust on Both Sides of the Pond
Pharmaceuticals had long been a focus of regulators and private plaintiffs and an area that regularly saw novel theories of harm. Whether it be the recently-in-focus Orange Book listings, developments in patent settlement law, M&A and exclusive licensing enforcement trends, or recent European decisions regarding the jurisdictional nexus required for enforcement, pharmaceutical antitrust law was constantly changing in the U.S. and Europe.
March 13, 2025
UK CMA and EU Competition Policy Shifts and Their Impact on Mergers and Antitrust Enforcement
The UK CMA had a new interim chair, explicitly tasked with leading the CMA on its mission to support growth under the government’s Plan for Change, following a meeting where regulators were asked to tear down the barriers hindering business. In parallel, the EU’s Executive Vice-President for a Clean, Just and Competitive Transition, Commissioner Ribera, had been made responsible for modernizing EU competition policy to support European companies in innovating, competing, and leading worldwide. What did this mean for mergers and behavioral and regulatory enforcement? Was there a shift in focus and prioritization? How did the trans-Atlantic rhetoric impact UK and EU antitrust?
February 13, 2025
Antitrust Policy and Enforcement in the Second Trump Administration
The second Trump administration had begun, and despite promises to unwind the Biden administration’s legacy of expansive antitrust enforcement, many of the incoming antitrust enforcers appeared more pro-enforcement than past Republican administrations. What did that mean for enforcement, mergers, and rulemaking? What kinds of cases were less or more likely? Which industries could expect less or more scrutiny? These may have seemed like hard questions to answer, but there had already been several signals that provided some insight into the Trump administration’s antitrust policy objectives and enforcement agenda.